Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQian Chu
About this trial
This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC.
The core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?
Eligibility criteria
Qualifiers
pathologically diagnosed non-small cell lung cancer
The treatment plan is：receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection
Disqualifiers
recurrent or metastatic lung cancer;
patients with other primary tumors
Trial design
Treatments tested in this trial
- Not listed
Trial groups
500 Participants
are grouped into 2 trial groupsLocations
2Tongji hospital430030, WuhanHubei, China
Sir Run Run Shaw Hospital430030, HangzhouZhejiang, China
Sponsors and collaborators
Qian Chu
Lead sponsor
Tongji Hospital
Sponsor institution
Source ClinicalTrials.gov